Advanced Heart Failure Cardiologist, Heart Function Clinic Physician Lead @RoyalColumbian. Clinical Assistant Prof @CardioUBC. he/him

Vancouver, British Columbia
Joined June 2013
Michael Diamant retweeted
Canadian Cardiovascular Congress 2026 The Right Patient at the Right Time: Percutaneous Mitral Valvular Intervention in Patients with Heart Failure 8:30 - 9:30 am Room 208 Co-Chair: Dr. Mustafa Toma Planning Committee: Dr. Michael Diamant Speaker: Dr. Miriam Shanks @mustoma @MDMichael13 @UBCCardio #HF #SHD #MedEd #CCC2026
1
1
86
Michael Diamant retweeted
Proposed New Conceptualization for Definition of Decompensated HF: Taking the Acute Out of Decompensation : Not ADHF, not specified by location such as hospital/ ED, not acute or urgent #JACCHF jacc.org/doi/10.1016/j.jchf.…
2
48
1
130
14,167
Michael Diamant retweeted
We studied the utility of in-hospital oral diuretic observation in the largest study to date. ahajournals.org/doi/10.1161/… We found: 1) the oral diuretic response during in-hospital observation correlated poorly with the outpatient diuretic response. (2/4) @CircHF @YaleHF
1
3
1
10
2,239
Michael Diamant retweeted
CAN-HF data showing broad eligibility for GDMT after AHF hospitalization in HFrEF & HFpEF @DrNatHawkins @ShelleyZieroth @DktrV @CCI_CIC @jaccjournals jacc.org/doi/10.1016/j.jchf.…
2
17
1
47
10,444
Michael Diamant retweeted
Amber Moore (she/her)@MsAmberJM22 Sep 2022
So excited to share the first piece from my postdoc research! 🗣️"SPEAKING MY MIND: A Public Service Announcement: Students Are Publishing Speak Homework as Fan Fiction" is in the latest issue of English Journal: library.ncte.org/journals/ej…
Michael Diamant retweeted
These are the primary results from the APOLLO-B @ISA_Amyloidosis #ISA_2022 presented by @MathewMaurer #Cardiotwitter
2
28
1
72
No benefit of PCI Vs OMT in the @REVIVED_BCIS2 trial in the risk of death or HF hospitalisation in patients with CAD and HFrEF Huge Glasgow input led by @markcpetrie20 with 83 patients randomised at @JubileeHospital Online now @NEJM nejm.org/doi/full/10.1056/NE…
1
16
1
51
Physicians from Royal Columbian's Cardiac Services were so inspired by the hard work of their colleagues during the pandemic that they're matching all gifts made before Mar 31. Give with heart, and your donation will be doubled: loom.ly/UTnIigc
1
1
11
Michael Diamant retweeted
With ICUs so full of Covid patients, BCers needing cardiac surgeries are waiting longer and longer They’re getting sicker, weaker, and increasingly needing urgent medical care That means a longer recovery that further strains the system @CTVVancouver 1/ bc.ctvnews.ca/waiting-longer…
14
84
7
199
Michael Diamant retweeted
🎉 CONGRATULATIONS! 📣 We are pleased to announce our 2021 #PatClifford Award Winners: Dr. Oyemolade Osibodu (PhD Graduate Category) @yorkuniversity @MoladeOsibodu & Dr. Amber Moore (PhD Student Category) @SFU @MsAmberJM Read the press release: ow.ly/2Jo150GMCSi
1
4
2
13
Michael Diamant retweeted
Our systematic review on atrial flutter and heart failure is available in @ESC_Journals In contrast to atrial fibrillation, there is little evidence looking at the implications of flutter on HF outcomes, nor dedicated trials to guide management decisions. doi.org/10.1002/ehf2.13526
5
27
1
89
#TOMAHAWK trial: early coronary #angiography in out-of-hospital #CardiacArrest patients without ST-segment elevation is not superior to a delayed/selective approach #ESCCongress
3
164
20
404
#APAF-CRT trial: ablation plus #CRT is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent #AFib patients with a narrow QRS #ESCCongress
10
201
23
396
Congratulations to @sfueducation postdoctoral fellow, Amber Moore (@MsAmberJM) on being awarded a Banting Postdoctoral Fellowship! Learn more about Amber: sfu.ca/gradstudies/life-comm…
1
2
1
14
#LIFE Trial #ACC21 Dr. Mann @ACCinTouch The LIFE trial tested the hypothesis that Sac/Val is superior to valsartan (Val) with respect to lowering NT-proBNP levels in patients with advanced HFrEF
2
9
1
30
💥#ACC21 #CAPITALCHILL trial for therapeutic hypothermia for OOH #cardiacarrest all initial rhythm randomized 389 pts 👉🏽target 🌡 31*C vs 34*C @ACCinTouch #ACCEarlyCareer ⭐️Target 🌡 31*C did not ⬇️ death/poor neurologic outcomes at 180d ⭐️⬆️ICU LOS in 31*C grp (10d vs 7d)
3
17
1
40
#RAFTAF #ACC21 Study Results: Primary Outcome (death or HF event) was not significantly different Primarily a study of Men (few women enrolled. Again.)
3
12
16